These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6135746)

  • 1. Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action.
    Reynolds GP; Rossor MN; Iversen LL
    J Neural Transm Suppl; 1983; 18():273-7. PubMed ID: 6135746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.
    Gurevich EV; Joyce JN
    Biol Psychiatry; 1997 Oct; 42(7):529-45. PubMed ID: 9376449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptors and the dopamine hypothesis of schizophrenia.
    Seeman P
    Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of dopamine receptors in the caudate nucleus and the putamen in schizophrenic brain.
    Mjörndal T; Winblad B
    Med Biol; 1986; 64(6):351-4. PubMed ID: 2881030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains.
    Noga JT; Hyde TM; Herman MM; Spurney CF; Bigelow LB; Weinberger DR; Kleinman JE
    Synapse; 1997 Nov; 27(3):168-76. PubMed ID: 9329152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug and transmitter receptors in human brain. Characterization and localization of serotonin, dopamine and adrenergic receptors.
    Maloteaux JM
    Acta Neurol Belg; 1986; 86(2):61-129. PubMed ID: 2873704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The involvement of 5-HT1a serotonin receptors in the pathophysiology and pharmacotherapy of schizophrenia].
    Maćkowiak M; Czyrak A; Wedzony K
    Psychiatr Pol; 2000; 34(4):607-21. PubMed ID: 11059260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex.
    Andree TH; Mikuni M; Tong CY; Koenig JI; Meltzer HY
    J Neurochem; 1986 Jan; 46(1):191-7. PubMed ID: 2866233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet 5-HT(2A) receptors in schizophrenic patients with and without neuroleptic treatment.
    Govitrapong P; Chagkutip J; Turakitwanakan W; Srikiatkhachorn A
    Psychiatry Res; 2000 Sep; 96(1):41-50. PubMed ID: 10980325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
    Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.
    Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL
    Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor mechanisms in the treatment of schizophrenia.
    Reynolds GP
    J Psychopharmacol; 2004 Sep; 18(3):340-5. PubMed ID: 15358977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585.
    East SZ; Burnet PW; Leslie RA; Roberts JC; Harrison PJ
    Synapse; 2002 Sep; 45(3):191-9. PubMed ID: 12112397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vivo study of central serotoninergic receptors in man using positron tomography].
    Baron JC; Samson Y; Comar D; Crouzel C; Deniker P; Agid Y
    Rev Neurol (Paris); 1985; 141(8-9):537-45. PubMed ID: 2935920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms.
    Kornhuber J; Riederer P; Reynolds GP; Beckmann H; Jellinger K; Gabriel E
    J Neural Transm; 1989; 75(1):1-10. PubMed ID: 2563750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY; Li Z; Kaneda Y; Ichikawa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the presence of D2 and 5-HT2 receptors in the human prefrontal cortex.
    Mita T; Kuno T; Nakai H; Tanaka C
    Jpn J Pharmacol; 1982 Dec; 32(6):1027-32. PubMed ID: 7161958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.